SARS-CoV-2 オミクロン・ブーストは,ヒトにおける新たなB細胞反応を誘発する
Wafaa B Alsoussi1, Sameer Kumar Malladi1, Julian Q Zhou1
1Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Nature
|April 3, 2023
まとめ
SARS-CoV-2 (重症急性呼吸器症候群コロナウイルス2) mRNAワクチンのブースターは生殖中心の反応を誘発し,B細胞の成熟と抗体の多様性を高めます. ブースターはまた,変種特有のエピトープを標的とした新しい反応を生成することができる.
科学分野:
- 免疫学
- ワクチン学
- ウイルス学
背景:
- 主要なSARS-CoV-2 (重症急性呼吸器症候群コロナウイルス2) mRNAワクチンシリーズは免疫性ですが,変種にはブースターと変種特有のワクチンが必要でした.
- ブースター予防接種は,主に既存の記憶B細胞を誘発しますが,生殖中心の反応と標的の変異エピトープを誘発する能力は不明です.
研究 の 目的:
- SARS-CoV-2 mRNAワクチンのブースターがヒトの生殖中心の反応を誘発するかどうかを調査する.
- 変種由来ワクチンが,変種特異的エピトープに反応するかどうかを判断する.
- 異なるmRNAワクチンのブースター戦略に従ってB細胞の反応を特徴づける.
主な方法:
- 人間の被験者はmRNAワクチンブースター (オリジナルまたは双価ベータ/デルタ) を受けた.
- ゲルミナルセンターB細胞反応,B細胞変異レベル,抗体結合プロフィールの分析.
- メモリとナイブB細胞からの単一クローン抗体の分離と特徴付け.
主要な成果:
- B細胞の突然変異と抗体の多様性を増加させる.
- 強化された個体からの単一クローン抗体は,主にオリジナルのSARS-CoV-2スパイクタンパク質を認識した.
- オミクロンBA.1変異を標的にする抗体のサブセットは,ナイブB細胞から発生し,変異特異性エピトープに対するデノボ応答を示した.
結論:
- SARS-CoV-2 mRNAワクチンのブースターは,有意な生殖中心のB細胞反応と抗体の成熟を誘発する.
- ブースターは新興のSARS-CoV-2変種に新たなエピトープを標的としたB細胞反応を誘発する.
- これらの発見は,ワクチン戦略が進化するウイルス株に対する免疫を拡大する可能性を強調しています.
関連する概念動画
Humoral Immune Responses
73.5K
Overview
73.5K
Immune Response Against Viral Pathogens
851
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
851
B Cell Activation and Differentiation
2.1K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
2.1K
Cell-mediated Immune Responses
69.4K
Overview
69.4K
Immunological Memory
1.0K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
1.0K
Antigens Involved in Adaptive Immunity
592
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
592


